- Home
- UHG vs STXS Comparison
UHG vs STXS Comparison
Compare UHG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHG
- STXS
- Stock Information
- Founded
- UHG 2004
- STXS 1990
- Country
- UHG United States
- STXS United States
- Employees
- UHG N/A
- STXS N/A
- Industry
- UHG Homebuilding
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- UHG Consumer Discretionary
- STXS Health Care
- Exchange
- UHG Nasdaq
- STXS Nasdaq
- Market Cap
- UHG 158.8M
- STXS 151.3M
- IPO Year
- UHG N/A
- STXS 2004
- Fundamental
- Price
- UHG $2.94
- STXS $2.28
- Analyst Decision
- UHG
- STXS
- Analyst Count
- UHG 0
- STXS 0
- Target Price
- UHG N/A
- STXS N/A
- AVG Volume (30 Days)
- UHG 243.0K
- STXS 288.7K
- Earning Date
- UHG 08-07-2025
- STXS 08-11-2025
- Dividend Yield
- UHG N/A
- STXS N/A
- EPS Growth
- UHG N/A
- STXS N/A
- EPS
- UHG 0.76
- STXS N/A
- Revenue
- UHG $449,877,017.00
- STXS $27,510,000.00
- Revenue This Year
- UHG N/A
- STXS $25.90
- Revenue Next Year
- UHG N/A
- STXS $60.57
- P/E Ratio
- UHG $4.06
- STXS N/A
- Revenue Growth
- UHG 5.24
- STXS 1.50
- 52 Week Low
- UHG $1.60
- STXS $1.54
- 52 Week High
- UHG $6.93
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- UHG 48.24
- STXS 56.94
- Support Level
- UHG $2.71
- STXS $2.12
- Resistance Level
- UHG $2.95
- STXS $2.36
- Average True Range (ATR)
- UHG 0.35
- STXS 0.10
- MACD
- UHG -0.04
- STXS 0.01
- Stochastic Oscillator
- UHG 24.43
- STXS 78.00
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.